Dermatology Billing and Coding: Medical vs Cosmetic
Quick Answer
Dermatology coding turns on documentation. Purpose decides medical versus cosmetic; lesion size, anatomical site and a separately identifiable E/M under modifier 25 decide whether codes like 11102 and 17000 get paid.
A CMS coverage policy draws the line the same way: reconstructive surgery treats abnormal structures and may be covered, while cosmetic surgery reshapes normal ones and is not. Pathology then picks the excision code family. If the note cannot say why, the claim cannot either.
Key Points
- CMS benign skin lesion article A54602 treats removal as medical, not cosmetic, when the record shows bleeding, intense itching or pain, a change in appearance, or realistic malignancy concern.
- CMS will not pay a separate same-day E/M such as 99214 alongside a minor procedure unless a significant, separately identifiable service is documented and billed with modifier 25.
- In a 2025 r/HealthInsurance thread, a longtime appeals writer recalled only 1 time an internal appeal changed anything, while external review is final and binding.
Lesion size and site go in the chart before the claim goes out.
Mixed cosmetic and medical practices hit one billing rule early: every same-day service for the same patient belongs on the same Part B claim. Medicare contractor Wellpoint Federal states the same-day rule plainly in its benign skin lesion billing article (A54602): Medicare "will not pay for a separate E & M service on the same day as a minor surgical procedure unless a documented significant and separately identifiable medical service is rendered." That is the reason for modifier 25. The same logic reaches Mohs surgery: a 2024 coding training video explains that a separate pathologist can bill for reviewing the slides only when the dermatologist formally requests a consultation, such as a second opinion on a complicated case.
The same article shows how fine the counting gets. Destruction code 17000 covers the first lesion, 17003 counts lesions 2 through 14, and 17004 covers 15 or more and is never billed with either of the others. Excision size is the lesion's greatest clinical diameter plus the narrowest margins required on each side, measured before the cut.
A 2026 dermatology coding cheat sheet asks for every lesion to be documented with its site, size, margins and count. Miss one. The code no longer matches the chart.
Then there is the cosmetic line. A purely cosmetic removal does not need to go to Medicare at all unless the patient asks for a formal denial, and the GY modifier flags a service as statutorily excluded. An ABN can warn the patient ahead of time when a service is likely to be non-covered, which beats explaining a surprise bill after the fact.
Follow-up visits carry their own trap: during a procedure's global period, the operating physician's separate visit is payable only for an unrelated problem, flagged with modifier 24. So before a follow-up is billed, check whether it falls inside the global period and whether the problem treated is truly unrelated.
Dermatology coding turns a skin visit into the CPT and ICD-10 codes a payer will accept, and in this specialty the chart settles most claims before they reach the clearinghouse. Medicare.gov describes cosmetic surgery as work that changes appearance rather than treating a medical condition, and says Medicare usually won't pay for it unless the patient needs it "because of accidental injury or to improve the function of a malformed body part."
Picture one patient. They booked cosmetic Botox, pointed to a darkened mole halfway through, and asked for an acne prescription on the way out. One visit now carries a patient-pay injection, a possible biopsy and a separate medical problem.
The rules keep moving, too. One Medicare contractor's cosmetic and reconstructive surgery policy was superseded with a revision ending 05/20/2026. An AI billing startup, Procode AI, told Fierce Healthcare in 2026 that human coders make surgical coding errors about 21% of the time, against about 9% for its own model. Those are the company's own figures, not an independent study. Software can catch a wrong code. It cannot add a lesion size nobody wrote down.
What no public figure settles yet is how often dermatology claims, specifically, get denied. The benchmarks that exist were built for medical practices in general.
I'll follow this patient through the boundary Medicare draws, the CPT codes behind each line, the modifier 25 rule for a same-day 99214, and the work of measuring and appealing denials. First comes the question of purpose, because the Botox and the mole cannot share one.
Questions this article answers
What separates medical from cosmetic dermatology coding?
Medicare draws the line by purpose, not by procedure name. A removal or injection is medical when the chart documents a symptom, a functional problem or real diagnostic doubt.
Before a lesion or injection goes on a claim, run the note through these questions:
- Is the target an abnormal structure (a lesion, defect or disorder) or a normal feature the patient wants changed?
- Does the note record a qualifying sign, such as bleeding, intense itching or pain, inflammation, or a change in appearance?
- Is there genuine doubt about the diagnosis, particularly where malignancy is a realistic concern?
- If all three answers are no, has the patient been told the service is self-pay before treatment starts?
Picture a patient booked for cosmetic Botox who points to a mole that has darkened and asks whether it should come off. Same room, same visit. Two very different claims. The mole sits on the medical side of the line only if the note says why.
The CMS billing and coding article A54602, Removal of Benign Skin Lesions, published by Medicare contractor Wellpoint Federal for its Midwest and Northeast states, spells this out. Its latest revision took effect on 04/01/2026, and it names the usual suspects: skin tags, milia, nevi, sebaceous cysts, papillomas, hemangiomas and viral warts. According to CMS, removing them is not considered cosmetic when the record shows bleeding, intense itching or pain, a change in appearance, inflammation or infection, obstruction of an orifice, restricted eye function, or clinical uncertainty where malignancy is a realistic consideration. It's worth noting that CMS frames that list as "including but not limited to," so it gives examples rather than a closed test.
Medicare.gov puts the other side bluntly. Beneficiaries "pay all costs for non-covered services, including most cosmetic surgery." The site defines cosmetic work as changing a person's appearance rather than treating a medical condition, and it flags botulinum toxin injections and blepharoplasty as services that are "sometimes (but not always) considered cosmetic."
Contractor coverage policy uses the same split. Reconstructive surgery treats abnormal structures caused by congenital defects, trauma, infection, tumors or disease, while cosmetic surgery reshapes normal structures to improve appearance and self-esteem. The diagnosis code then carries that judgment onto the claim. Suspicious lesions and cosmetic removals use different diagnosis codes, and a removal billed under the wrong one gets denied.
The common assumption is that the procedure decides coverage. It doesn't. A comparison of 4 sources shows the same rule every time: documented purpose = covered, missing purpose = patient-pay. Warts get extra triggers of their own, such as periocular warts with chronic recurrent conjunctivitis, or genital warts linked to cervical dysplasia or pregnancy. One missing symptom turns a covered removal into a surprise bill.
Why settle this before the visit rather than after the denial? Because the cosmetic line is a scheduling and verification question as much as a coding one. HelpSquad was named a Clutch 2026 Top Medical Billing Company, and my view from my own billing work at Optum is simple: get the purpose on paper before the patient is in the chair. That is also why coverage checks sit near the top of any list of tasks worth outsourcing in a medical practice. Once the reason for removing that darkened mole is documented, the next question is which code tells the payer what was actually done to it.
Why do medically necessary skin procedures still get denied as cosmetic?
In August 2025, a patient posted online that an insurer had denied a dermatology removal as cosmetic. The people who replied barely argued about the procedure. Several of them pointed to one code.
"There are specific codes for suspicious skin lesions and ones to specify cosmetic," one commenter wrote in r/HealthInsurance. Another told the patient to ask the billing office to "resubmit just that charge with a diagnosis code for a pre-cancerous lesion." A third said the notes had to state that the lesion was precancerous and medically necessary to remove. Nobody suggested changing the procedure code.
Outside dermatology, a patient in another thread got repeated "not medically necessary" denials for an MRI of the femur and hip, then learned from an outside review that the office had coded the reason as "knee pain." "Medical Necessity rules are often triggered by the presence or absence of a specific diagnosis," another commenter there explained. One commenter in the lesion thread also warned that some insurers "may consider cosmetic regardless of the reason."
Mixed visits can break the line in the other direction. In 2023, a patient wrote that two cosmetic Botox visits with the same dermatologist had been billed to insurance, with a copay each time. At those visits the patient had asked about a bleaching cream, a recovery time and a tretinoin prescription. According to the patient, the billing office said everything discussed had to be documented, and the resulting codes triggered the claim. The patient disputed parts of the chart, and we have only the patient's side.
Medicare writes the same-day line into the record: a separate evaluation on the day of a minor procedure is payable only for "a documented significant and separately identifiable medical service," billed with modifier 25. A former dermatology staff member in the Botox thread described patients who sent screenings and excisions to insurance and paid for more frequent visits themselves. Another commenter said most offices keep a form stating "this visit will not be billed to insurance."
CMS also lets practices mark cosmetic work before it reaches a claim. Its benign lesion article says purely cosmetic removals "may not necessarily need to be submitted to Medicare unless the patient requests that a formal Medicare denial is issued." The GY modifier flags services that are "statutorily non-covered," and an Advance Beneficiary Notice may be used when non-coverage is likely. For services Medicare.gov calls "sometimes (but not always)" cosmetic, including botulinum toxin injections and blepharoplasty, Medicare usually requires prior authorization, filed by the provider, when the procedure is done in a hospital outpatient department or an ambulatory surgical center.
Once a claim is refused, the label on the denial matters. The law handles cosmetic exclusion and medical necessity in separate places, and the federal external review rule for private plans covers adverse decisions that involve "medical judgment," including medical necessity.
| Denied as not medically necessary | Denied as a cosmetic exclusion | |
|---|---|---|
| Social Security Act | §1862(a)(1)(A): covers reasonable and necessary services | §1862(a)(10): excludes cosmetic surgery |
| Medicare Benefit Policy Manual, Ch. 16 | §20, Services Not Reasonable and Necessary | §120, Cosmetic Surgery |
| External review, private plans | Covered when the decision involves medical judgment (45 CFR 147.136) | Often available when the doctor documents medical necessity; state rules vary |
| Fix described in our sources | Documentation that refutes the stated reason | A corrected diagnosis code, if the note supports a medical reason |
A commenter who said they had handled appeals for years described up to three internal levels, then an external review that is "final and binding."
"Just expect the internal appeals to all be denied, because I've been doing this for years at this point and I can only think of 1 time an internal appeal actually did anything."
Commenter in r/HealthInsurance who handles appeals, 2025
The same commenter had "yet to lose an external appeal." Another said external review opens only for "truly a medical necessity denial," and "not an exclusion." A third said purely cosmetic care also gets denied as "not medically necessary," so the letter's wording may not reveal which route is open. State regulators, and the NAIC model act many states base their rules on, treat a dispute over whether a cosmetic exclusion applies, when the doctor says the care is medically necessary, as eligible for external review.
Follow a cosmetic denial from the exam room to the appeal and the question gets answered once, then copied. The note records why a lesion came off or a question was asked. The diagnosis code carries that reason to the payer. A modifier, a GY flag or a non-billing form sorts the visit, and the denial label decides which appeal routes stay open. Each step can pass along or garble the note, but none can add a reason the note never recorded.
- Before a lesion removal claim goes out, compare its diagnosis code with the reason in the note. If the note describes a suspicious or changing lesion and the claim reads as cosmetic, fix the claim first.
- Before spending time on an appeal, ask the payer whether it will accept a corrected claim with a more specific diagnosis.
- When a Botox visit picks up a medical question, decide in the room whether it is a separately identifiable service for modifier 25, and offer a separate encounter or a non-billing form for the cosmetic part.
- For Medicare patients, add the GY modifier to statutorily excluded work, issue an ABN when non-coverage is likely, and start prior authorization early for services such as blepharoplasty.
- Read every cosmetic denial for its stated reason and cited policy, then ask whether a physician reviewed it against medical policy or the plan denied it under a benefit exclusion.
How we checked this
We read a CMS billing and coding article on benign skin lesions (revision effective April 1, 2026), a superseded CMS local coverage determination for its statutory citations, Chapter 16 of the Medicare Benefit Policy Manual, Medicare.gov coverage guidance and the federal external review rule. We also read three Reddit threads from 2023 and 2025. None of the figures here are ours. The forum posts are individual accounts from people whose identities and claims we could not verify, and they cannot show how often these denials happen. The CMS lesion article applies to specific Medicare contractor regions. The external review rule covers private plans, and none of our sources described Medicare's own appeal route for an excluded service. The CMS lesion article cites Chapter 16, §20 for the cosmetic exclusion, while the manual lists cosmetic surgery under §120. HelpSquad provides billing and front-office support to healthcare practices, including denial follow-up, so we have a stake in this topic. Still unknown: how often cosmetic denials come from coding errors and how often from payer policy.
- CMS, billing and coding article A54602 on removal of benign skin lesions, revision effective April 1, 2026.
- CMS, LCD L39506 on cosmetic and reconstructive surgery, current version effective May 21, 2026.
- CMS, Medicare Benefit Policy Manual, Chapter 16, retrieved October 14, 2026.
- Medicare.gov, cosmetic surgery coverage page, retrieved October 2026.
- eCFR, 45 CFR 147.136 on internal appeals and external review, retrieved October 14, 2026.
- r/HealthInsurance, thread on a lesion removal denied as cosmetic, August 24, 2025.
- r/HealthInsurance, thread on appealing a not medically necessary denial, February 13, 2025.
- r/CodingandBilling, thread on copays for cosmetic Botox visits, August 31, 2023.
Which dermatology CPT codes drive denials, and what decides each one?
Dermatology CPT codes turn on five details: technique, intent, size with margins, pathology and lesion count. Miss one and the claim no longer matches the note.
Here is how those five details map to the code families a dermatology practice bills every week.
| Code family | Detail that picks the code | What the note must show |
|---|---|---|
| Biopsy (CPT 11102 is a tangential biopsy of a single lesion) | Technique: tangential, punch or incisional | Technique, site, and that the goal was diagnosis |
| Shave removal | Intent to treat rather than sample | Why the lesion was removed, not just sampled |
| Excision | Lesion size plus margins; benign or malignant pathology | Diameter, margin, site and the pathology result |
| Destruction (CPT 17000 covers the first premalignant lesion) | Number of lesions treated | An exact lesion count and each site |
| Repair | Simple, intermediate or complex closure | Closure type, because simple repair is already part of the excision |
A 2026 Coding Clarified dermatology cheat sheet lays the rules out plainly. Biopsy codes depend on technique. A biopsy samples tissue for diagnosis, while a shave removal treats the lesion, and the video tells coders to "measure the lesion plus the margins, not the lesion alone." Because benign and malignant excisions use different code families, the pathology report has to be read before the code is chosen. Destruction is its own family too, and the lesion count changes the code.
Intent matters as much as technique. Biopsy versus excision depends on what the surgeon set out to do at the time, not on what ended up in the specimen jar. If the plan was full removal, the service is an excision even when the first pass misses clear margins, and a planned second procedure carries modifier 58 so the payer reads it as a continuation. A biopsy and an excision of the same lesion cannot both be billed on the same date of service. The margin detail is easy to underrate, yet adding it can push a procedure into a different, higher code.
Back to our patient with the darkened mole. If the dermatologist meant only to sample it, that is a biopsy coded by technique. If the plan was to take the whole thing, it is an excision, sized with its margins and coded from whichever family pathology picks. The diagnosis side needs the same care: ICD-10 expects coding to the highest available specificity, and neoplasm codes carry laterality, so "eyelid" is not enough when the code asks right or left.
Accuracy also cuts the other way. In a 2023 r/CodingandBilling thread, a patient who came in for cosmetic Botox reported that the chart recorded acne counseling that never happened, and billing staff described the insurance claim as something the documentation triggered automatically. A commenter explained that tretinoin is classed as an acne prescription, so an acne discussion usually precedes it. Our patient asks for that same prescription on the way out.
I'd treat any note written to fit a code as an audit risk, not a shortcut. Code from what happened. Nothing else.
Code selection belongs to a certified coder, not the front desk. Where a medical virtual assistant team can help is the checklist work around it: flagging a lesion line with no size, a destruction with no count, or an excision claim sent before pathology returned. And the excision is only half of that visit's claim, because the evaluation that found the mole needs its own support.
How should a dermatology practice measure, appeal and prevent denials?
Track a few revenue numbers every month, read each denial for its stated reason, appeal medical-necessity denials with the chart, and make sure a certified coder reviews procedures before submission.
Go back to the Botox patient with the darkened mole. If the dermatologist biopsies it with 11102 and also bills a 99214, modifier 25 has to show the payer that a significant, separately identifiable evaluation happened on the same day as the procedure. The note must prove it. A one-line mention of a mole hands the payer three familiar reasons to deny: no lesion size, no anatomical site, and nothing that supports a separate E/M.
My read is that the acne complaint and the tretinoin prescription are the likelier home for that separate evaluation, but only when the note records them as their own problem. Is one visit worth this much scrutiny? Yes, because whatever the template leaves out on this chart, it leaves out on the next one too.
Measurement is how you spot the pattern. A dermatology software vendor's 2022 billing guide, citing a 2017 benchmarking book, put a healthy net collection ratio at 96% to 99%, days in A/R at 45 days or less, and the share of A/R older than 90 days at 12% to 15%. The same vendor, in 2020, gave 5 to 10 percent as the industry denial-rate benchmark and 5 percent or less for clearinghouse and payer rejections.
Treat those as one vendor's yardsticks, not a dermatology standard. They still give you a monthly baseline. A denial rate that climbs after a heavy injectables month tells you where to look.
Next, read every denial for its stated reason. In a 2025 r/HealthInsurance thread, a longtime appeals writer said insurers must send a medical-necessity denial in writing with a clear explanation, and described 3 layers of internal appeals followed by an external appeal that is final and binding. That commenter could recall only 1 time an internal appeal changed anything, and had "yet to lose an external appeal." Another commenter in the same thread drew a line that matters for a mixed practice: external review is open to medical-necessity disputes, not to services that are plainly cosmetic. A medical lesion denied as cosmetic usually counts as a medical-necessity dispute once the chart backs it up, though state rules vary.
Apply that to our patient. The cosmetic Botox line is a true exclusion, so it stays patient-pay, and no appeal changes it. A biopsy denied as not medically necessary is different. Size, site and suspicious features in the note = the APPEAL.
Prevention is a staffing question. On r/CodingandBilling in 2025, a small-practice owner learned that their percentage-fee billing vendor did no coding at all, and commenters explained that billing is usually priced as a percentage of payments while coding is charged hourly or per chart. One commenter put the split bluntly: "billing can be done by a coder, but coding shouldn't be done by a biller."
Whether you hire in-house or compare healthcare BPO services, ask the same two questions. Who reads the chart and assigns the codes? Who only submits the claim and chases it afterward? That second job starts well before any denial, at the front desk, the moment the patient's insurance is checked.
Will AI billing tools fix dermatology coding denials?
Not on their own. The practical fix sits upstream, at scheduling and insurance verification, where staff flag mixed cosmetic and medical visits. Software and new vendors can only code what the chart already says.
Money is moving toward automation anyway. Fierce Healthcare quoted Procode AI co-founder Jeff Cripe putting outsourced medical billing at a $15 billion industry growing about 13% per year, and the same report noted that all medical claims still go through human review. Contrary to the excitement around AI coding, that last detail is the one worth holding onto.
Here's where I come down. Ask any AI vendor a blunt question: when the note is silent on size or site, does the tool send the gap back to the provider, or code around it? If the note never records the mole's size or site, or never treats the acne as its own problem, no model can bill it cleanly. Then ask who will own your account if the vendor is sold, since AI buyers are already acquiring dermatology billing firms.
So before comparing vendors, pull last month's denials and read each stated reason. Then look at what the front desk captured before each of those visits began.
Frequently Asked Questions
What else do practices ask about dermatology billing and coding?
Most follow-up questions come down to who files what, when a cosmetic and a medical service can share one visit, and what outside help costs.
Who is responsible for prior authorization on a Botox or eyelid procedure?
The provider is. Prior authorization is the approval a provider requests from the payer, with supporting documentation, before the procedure, and the patient does not need to do anything. It can apply whether the service happens in a hospital outpatient department or an ambulatory surgical center. Once it is approved, the patient should only owe the deductible and coinsurance.
Can a cosmetic service and a medical problem be billed on the same day?
Yes, as separate lines with separate purposes. The cosmetic injection stays patient-pay, while a suspicious lesion or an acne complaint goes to insurance only if the note documents it as its own problem. My advice: never let one medical question turn the whole visit into an insurance claim.
What does modifier 25 mean on a dermatology claim?
Modifier 25 is appended to an evaluation and management code, such as 99214, to show that a significant, separately identifiable evaluation happened on the same day as a procedure. Without notes that support that separate work, expect the E/M line to deny.
Can EHR software code a dermatology visit automatically?
Partly. One dermatology EHR vendor's 2015 launch announcement promoted "automated and advanced ICD-10 coding," but software can only code what the note says. If the note never records the lesion's size, site or symptoms, the automated code comes out just as incomplete.
What does outsourced dermatology front-office support cost?
HelpSquad charges $8-$13/hour for full-time staffing, with HIPAA compliance, bilingual agents and dedicated account management. Part-time schedules are quoted individually. To start, book an intro call through helpsquad.com/contact or call 877-775-3667, and bring last month's denial reasons to that conversation.
Written by
Maria Rush
Marketing Team Lead, HelpSquad
Maria De Jesus-Rush is Marketing Team Lead at HelpSquad, a healthcare business process outsourcing company, with a background in content development, digital marketing, and project management.
Connect on LinkedIn
What Is Insurance Eligibility Verification in Healthcare?
Published June 2026 • Updated July 8, 2026 • By Maria Rush, Marketing Team Lead, HelpSquad
Dental Billing Process & Guidelines: Cross-Billing & Claims
Dental billing is the process of submitting claims to dental and, when procedures qualify, medical insurance to collect payment for dental services.
Behavioral Health Revenue Cycle Management: A Guide for Mental Health Practices
Behavioral health revenue cycle management is the process of managing every financial step in a mental health practice, from eligibility verification and prior authorization to claim submission, denial management, and payment collection.
Let's talk about what your practice actually needs.
A 30-minute call. No sales pressure. We'll tell you honestly whether we're a fit.